Yearly Archives: 2024

This week the MHRA announced that codeine linctus would be reclassified to a prescription-only medicine because of the risk of abuse and addiction that comes with it being available over-the-counter. Please see more information here: Codeine linctus to be reclassified to a prescription-only medicine because of risk of abuse and addiction – GOV.UK (www.gov.uk) We [...]

The post Codeine Linctus reclassification from P to POM appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (23/02/2024) announced the following list of price concessions for February 2024. Please note: We are still in discussion with DHSC on a number other medicines affected by pricing [...]

The post February 2024 Price Concessions 3rd Update appeared first on Community Pharmacy England.

NHS England has written to pharmacy teams to provide further details on the Spring 2024 COVID-19 vaccination campaign including information on timings of the campaign. The letter says that visits to vaccinate patients in older adult care homes and eligible housebound patients should begin on 15th April 2024. For all other eligible cohorts, vaccinations should [...]

The post C-19 vacs: Preparing for a successful Spring 2024 vaccination campaign appeared first on Community Pharmacy England.

Eli Lilly and Company Ltd has recently launched Mounjaro® (tirzepatide), a new diabetes drug which is also indicated for the treatment of weight loss. Mounjaro® comes in a KwikPen® or auto-injector pre-filled injection pen containing 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg of tirzepatide. Currently, only the 2.5mg and 5mg strengths of the KwikPen® are [...]

The post Mounjaro® (Tirzepatide) KwikPen® – availability and reimbursement appeared first on Community Pharmacy England.